Clinical Trial Update: Evaluating HA 0.15% Compared With Cyclosporine 0.05%, and Efficacy of Combination Therapy in Dry Eye Disease Patients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing HA 0.15% to cyclosporine 0.05% and evaluating combination therapy in dry eye disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye
• Dry Eye Syndromes

Drugs mentioned

• Cyclosporine 0.05%
• HA 0.15%

Snippet

Sponsor: Taejoon Pharmaceutical Co., Ltd. | Conditions: Dry Eye, Dry Eye Syndromes | Phase 4 | Status: COMPLETED